Quarterly Results

CLARIS LIFESCIENCES LTD.

NSE : NABSE : 533288ISIN CODE : INE562G01018Industry : TradingHouse : Private
BSE396.550 (0 %)
PREV CLOSE ( ) 396.55
OPEN PRICE ( ) 395.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 396.55 (187)
VOLUME 76598
TODAY'S LOW / HIGH ( )395.00 396.90
52 WK LOW / HIGH ( ) 395396.9
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2017
Sep 2017
Jun 2017
Mar 2017
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
20.66
43.1
31.32
44.11
Total Expenditure
150.87
156.91
206.14
180.58
PBIDT (Excl OI)
-130.21
-113.81
-174.82
-136.47
Other Income
594.19
441.51
95.04
93.16
Operating Profit
463.98
327.7
-79.78
-43.31
Interest
7.72
7.6
9.03
10.92
Exceptional Items
NA
NA
NA
NA
PBDT
456.26
320.1
-88.81
-54.23
Depreciation
11.44
11.13
10.98
16.17
Profit Before Tax
444.83
308.98
-99.79
-70.4
Tax
16.34
113.76
-26.15
-49.66
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
428.49
195.22
-73.64
-20.74
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-3174.3
18402.74
208.33
405.39
Minority Interest
NA
NA
NA
NA
Shares of Associates
-16.25
-35.75
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-3174.3
18402.74
192.08
369.64
Equity Capital
545.68
545.68
545.68
545.68
Face Value (IN RS)
10
10
10
10
Reserves
NA
NA
NA
NA
Calculated EPS
-58.17
337.24
3.52
6.77
Calculated EPS (Annualised)
-232.68
1348.97
14.08
27.09
No of Public Share Holdings
27211801
27211801
27211801
27211801
% of Public Share Holdings
49.87
49.87
49.87
49.87
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-630.25
-264.06
-558.17
-309.38
PBIDTM%
2245.78
760.32
-254.72
-98.18
PBDTM%
2208.47
742.71
-283.55
-122.94
PBTM%
2153.09
716.89
-318.61
-159.60
PATM%
2074.00
452.94
-235.12
-47.01
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.